- Home
- NPWR vs DERM Comparison
NPWR vs DERM Comparison
Compare NPWR & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NPWR | DERM |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.9M | 210.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NPWR | DERM |
|---|---|---|
| Price | $2.14 | $8.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $3.50 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 822.2K | 123.8K |
| Earning Date | 03-09-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $59,399,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | N/A | $55.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.86 | 2.82 |
| 52 Week Low | $1.48 | $4.67 |
| 52 Week High | $8.87 | $9.56 |
Technical Indicators
Market Signals| Indicator | NPWR | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 31.74 | 53.95 |
| Support Level | $1.96 | $8.22 |
| Resistance Level | $2.43 | $8.78 |
| Average True Range (ATR) | 0.14 | 0.58 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 12.12 | 43.95 |
Price Performance
Historical ComparisonAbout NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.